{"altmetric_id":10197741,"counts":{"readers":{"mendeley":29,"citeulike":0,"connotea":0},"total":{"posts_count":2},"news":{"unique_users_count":1,"unique_users":["seeking_alpha"],"posts_count":1},"blogs":{"unique_users_count":1,"unique_users":[55276],"posts_count":1}},"citation":{"altmetric_jid":"4f6fa50e3cf058f6100031c4","authors":["Drazen JM","O'Byrne PM","Drazen, Jeffrey M.","O'Byrne, Paul M."],"doi":"10.1056\/nejme0902057","endpage":"1672","first_seen_on":"2016-08-02T04:43:02+00:00","issns":["0028-4793","1533-4406"],"issue":"16","journal":"New England Journal of Medicine","last_mentioned_on":1469886721,"links":["http:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMe0902057","http:\/\/dx.doi.org\/10.1056\/NEJMe0902057"],"pmid":"19369675","pubdate":"2009-04-15T23:00:00+00:00","publisher":" Massachusetts Medical Society ","publisher_subjects":[{"name":"Medical And Health Sciences","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"startpage":"1671","subjects":["medicine"],"title":"Risks of Long-Acting Beta-Agonists in Achieving Asthma Control","type":"article","uri":"http:\/\/www.nejm.org\/doi\/abs\/10.1056\/NEJMe0902057","volume":"360","mendeley_url":"http:\/\/www.mendeley.com\/research\/risks-longacting-betaagonists-achieving-asthma-control"},"altmetric_score":{"score":12.136,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":12.136},"context_for_score":{"all":{"total_number_of_other_articles":8156965,"mean":6.8933631772734,"rank":674568,"this_scored_higher_than_pct":91,"this_scored_higher_than":7482408,"rank_type":"exact","sample_size":8156965,"percentile":91},"similar_age_3m":{"total_number_of_other_articles":257646,"mean":11.991726414252,"rank":32194,"this_scored_higher_than_pct":87,"this_scored_higher_than":225452,"rank_type":"exact","sample_size":257646,"percentile":87},"this_journal":{"total_number_of_other_articles":20101,"mean":47.575929452736,"rank":7479,"this_scored_higher_than_pct":62,"this_scored_higher_than":12619,"rank_type":"exact","sample_size":20101,"percentile":62},"similar_age_this_journal_3m":{"total_number_of_other_articles":317,"mean":153.85516455696,"rank":223,"this_scored_higher_than_pct":29,"this_scored_higher_than":94,"rank_type":"exact","sample_size":317,"percentile":29}}},"demographics":{"users":{"mendeley":{"by_status":{"Professor > Associate Professor":2,"Student  > Doctoral Student":1,"Researcher":6,"Student  > Ph. D. Student":1,"Student  > Postgraduate":3,"Student  > Master":1,"Other":6,"Student  > Bachelor":2,"Lecturer":1,"Lecturer > Senior Lecturer":2,"Professor":4},"by_discipline":{"Medicine and Dentistry":26,"Immunology and Microbiology":1,"Agricultural and Biological Sciences":2}}},"geo":{"mendeley":{"NZ":1,"CO":1,"BE":1,"US":1}}},"posts":{"news":[{"title":"Innoviva: Finally Starting To Gain Some Trust","url":"http:\/\/ct.moreover.com\/?a=27445793284&p=1pl&v=1&x=p-nPuDIcSMmUbUcEmpaTDA","license":"public","citation_ids":[10197741],"posted_on":"2016-07-30T13:52:01+00:00","summary":"The Ellipta range of respiratory drugs Quarterly figures The Innoviva (NASDAQ: INVA ) report came one day after GlaxoSmithKline (NYSE: GSK ) had already disclosed Q2 sales figures for the partnered drugs Breo and Anoro.","author":{"name":"Seeking Alpha","url":"http:\/\/seekingalpha.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/665\/normal\/Screen_Shot_2016-01-26_at_13.35.16.png?1453815336"}}],"blogs":[{"title":"Effect of Vitamin D3 on Asthma Treatment Failures in Adults With Symptomatic Asthma and Lower Vitamin D Levels","url":"http:\/\/dx.doi.org\/10.1001\/jama.2014.5052","license":"public","citation_ids":[4802719,838187,838187,182643,182643,178525,178525,228390,228390,1483654,1483654,191777,191777,16660160,16660160,18175165,18175165,18175168,18175168,375470,375470,18175178,18175178,18175181,18175183,18175190,16020176,5907801,5907801,11951164,11951164,231134,231134,1444725,1444725,2840184,2840184,4815419,4815419,4496194,4496194,18175207,18175211,5993449,5993449,16862795,16862799,975511,975511,16862810,16862810,10197741,10197741,1721629,1721629],"posted_on":"2014-05-18T21:00:00+00:00","summary":"Interview with Mario Castro, MD, author of Effect of Vitamin D3 on Asthma Treatment Failures in Adults With Symptomatic Asthma and Lower Vitamin D Levels","author":{"name":"JAMA Author Interviews","url":"http:\/\/jama.jamanetwork.com\/multimedia.aspx#AuthorInterviews","description":"Interviews with Authors of JAMA Articles"}}]}}